Zhao R. Liang

No. 253, Industrial Avenue
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Targeting CARM1 impairs DNA damage repair and attenuates B-cell acute lymphoblastic leukemia progression.

Targeting CARM1 impairs DNA damage repair and attenuates B-cell acute lymphoblastic leukemia progression.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: November 17, 2025

Targeting KAT7 inhibits the progression of colorectal cancer.

Targeting KAT7 inhibits the progression of colorectal cancer.

Journal: Theranostics

Published: October 30, 2024

Inhibition of Tumoral VISTA to Overcome TKI Resistance via Downregulation of the AKT/mTOR and JAK2/STAT5 Pathways in Chronic Myeloid Leukemia.

Inhibition of Tumoral VISTA to Overcome TKI Resistance via Downregulation of the AKT/mTOR and JAK2/STAT5 Pathways in Chronic Myeloid Leukemia.

Journal: Biomolecules & therapeutics

Published: January 22, 2024

Targeting PARP14 with lomitapide suppresses drug resistance through the activation of DRP1-induced mitophagy in multiple myeloma.

Targeting PARP14 with lomitapide suppresses drug resistance through the activation of DRP1-induced mitophagy in multiple myeloma.

Journal: Cancer letters

Published: November 26, 2023

Donor-derived CAR-T therapy improves the survival of relapsed B-ALL after allogeneic transplantation compared with donor lymphocyte infusion.

Donor-derived CAR-T therapy improves the survival of relapsed B-ALL after allogeneic transplantation compared with donor lymphocyte infusion.

Journal: Human cell

Published: March 15, 2023

Current state of CAR-T therapy for T-cell malignancies.

Current state of CAR-T therapy for T-cell malignancies.

Journal: Therapeutic advances in hematology

Published: July 15, 2022

A method of screening highly common neoantigens with immunogenicity in colorectal cancer based on public somatic mutation library

A method of screening highly common neoantigens with immunogenicity in colorectal cancer based on public somatic mutation library

Journal: Yi chuan = Hereditas

Published: July 23, 2020

Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas.

Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas.

Journal: Frontiers in immunology

Published: May 20, 2020

Shortening the ex vivo culture of CD19-specific CAR T-cells retains potent efficacy against acute lymphoblastic leukemia without CAR T-cell-related encephalopathy syndrome or severe cytokine release syndrome.

Shortening the ex vivo culture of CD19-specific CAR T-cells retains potent efficacy against acute lymphoblastic leukemia without CAR T-cell-related encephalopathy syndrome or severe cytokine release syndrome.

Journal: American journal of hematology

Published: May 10, 2019

NeoPeptide: an immunoinformatic database of T-cell-defined neoantigens.

NeoPeptide: an immunoinformatic database of T-cell-defined neoantigens.

Journal: Database : the journal of biological databases and curation

Published: December 18, 2018

Overexpression of EPS8 is associated with poor prognosis in patients with acute lymphoblastic leukemia.

Overexpression of EPS8 is associated with poor prognosis in patients with acute lymphoblastic leukemia.

Journal: Leukemia research

Published: October 29, 2014

The geometry of the bone structure associated with total hip arthroplasty.

The geometry of the bone structure associated with total hip arthroplasty.

Journal: PloS one

Published: May 28, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026